III. Proton-therapytherapy. Rome SB - 5/5 1

Size: px
Start display at page:

Download "III. Proton-therapytherapy. Rome SB - 5/5 1"

Transcription

1 Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier of cancer radiation therapy Proton-therapytherapy Carbon ion therapy Neutrons in cancer therapy V Rome SB - 5/5 1

2 Hadrontherapy with beams of protons and ions Rome SB - 5/5 2

3 Charged particles in matter The Bethe-Bloch Bloch formula: = = MeV / (g/cm 2 ) dx expressed in g/cm 2 Notes: Ionization + eccitation MIP = Minimum Ionizing Particle MIP in water 2.0 MeV/cm 0.2 ev/nm very low LET radiation! Rome SB - 5/5 3

4 The basic concept of hadrontherapy Fundamental physics Particle identification L3 at LEP Medical applications Cancer hadrontherapy Rome SB - 5/5 4

5 The Bragg peak Straggling and multiple scattering Fragmentation Rome SB - 5/5 5

6 Single beam comparison X rays Protons or Carbon ions Rome SB - 5/5 6

7 Protons and ions are more precise than X X--rays Tumour between the eyes 9 X ray beams Rome SB - 5/5 1 proton beam 7

8 The first idea Bob Wilson, 1946 Bob Wilson was student of Lawrence in Berkley Study of the shielding for the new cyclotron Interdisciplinary i environment = new ideas! Use of protons and charged hadrons to better distribute the dose of radiation in cancer therapy R.R. Wilson, Radiology, 47 (1946) 487 Rome SB - 5/5 8

9 The beginning of hadrontherpay 1954 at Berkeley C.A. Tobias, J.H. Lawrence et al., Cancer Research 18 (1958) 121 Rome SB - 5/5 9

10 The basic principles of hadrontherapy Protons 200 MeV 1nA 27 cm Tumour targett Carbon ions 4800 MeV 0.1 na Beam of hadrons which slow down in matter Bragg peak Better conformity of the dose to the target t healthy tissue sparing Hadrons are charged Beam scanning for dose distribution Heavy ions Higher biological effectiveness Rome SB - 5/5 10

11 Energy and current Why 200 MeV protons and 400 MeV/u C ions? Range in water: 200 MeV p 27 cm penetration depth 4800 MeV C ions 27 cm penetration depth Why 1 na current? Requirement: 2 Gy per Kg per minute (2 J / 200 MeV) x (e) x (1/60 sec) 1 na Rome SB - 5/5 11

12 Why ions have a large biological effectiveness? X RBE = 1 RBE = 3 quantum Break of a single/double helix of DNA carbon ion 40 mm from the end of the range electron ionization Multiple breaks of both helixes cannot tbe repaired cromosome Ions have high LET (Linear Energy Transfer) Rome SB - 5/5 12

13 The eye melanoma treatment at INFN-LNS in Catania LNS Supercoducting cyclotron 65 MeV protons 92 patients (oct 2005) Rome SB - 5/5 13

14 First hospital-based proton-therapy therapy centre, built in 1993 ~160/sessions a day ~1000 patients/year The Loma Linda University Medical Center (USA) Rome SB - 5/5 14

15 Dose distribution: passive spreading Double scattering Layer stacking Rome SB - 5/5 15

16 Standard procedure: Passive beam spreading with respiratory gating Double scatterer Collimator Bolus: has to be machined for each case. Rome SB - 5/5 16

17 Advanced procedure: layer stacking with respiratory gating Collimator adapted to transverse shape of each slice. Rome SB - 5/5 17

18 Passive spreading: the nozzle Ionization chamber Propeller Quadrant ionization chamber Beam Rome SB - 5/5 18

19 Passive spreading: calibration before treatment Collimator Bolus Water equivalent absorber Ionization chamber Rome SB - 5/5 19

20 Passive spreading: personalized devices Propeller Collimator Bolus - prostate Bolus - liver Rome SB - 5/5 20

21 Dose distribution: active scanning Longitudinal plane Transverse plane patient fast slow beam horizontal scanning vertical scanning beam tumour volume energy variation New technique developed mainly at GSI and PSI Rome SB - 5/5 21

22 Active spot scanning a la PSI 1 2 Single spot Lateral scanning with magnet: 2 ms/step 3 4 Depth scanning with upstream absorbers Depth scanning Third scanning by a bending magnet and movable bed Rome SB - 5/5 22

23 High precision RT with proton beams Rome SB - 5/5 23

24 High precision RT with proton beams Rome SB - 5/5 24

25 High precision RT with proton beams Rome SB - 5/5 25

26 High precision RT with proton beams Rome SB - 5/5 26

27 Front-end boards A detector for spot scanning: The strip chamber developed by TERA for PSI Mylar window Mylar window U Anode In collaboration with University and INFN Torino 2-sided aluminized cathode T Anode Rome SB - 5/5 27

28 Beam tests on Gantry1 at PSI SAMBA Strip Accurate Monitor for Beam Applications Measurement of a spot Rome SB - 5/5 28

29 Time profile of the clinical beams Tota al Intensit ty SPOTS Average flat top current 0.2 na Time 5 ms Rome SB - 5/5 29

30 A line of dose made of spots Rome SB - 5/5 30

31 Number of potential patients Study by AIRO, 2003 Italian Association for Oncological Radiotharapy X-ray therapy every 10 million inhabitants: 20' pts/year Protontherapy 14.5% of X-ray patients = 2'900 pts/year Therapy with Carbon ions for radio-resistant resistant tumours 3% of X-ray patients = 600 pts/year Every 50 M inhabitants Proton-therapytherapy 4-5 centres Carbon ion therapy 1 centre TOTAL about 3'500 pts/year every 10 M Rome SB - 5/5 31

32 The sites Up to present Proton-therapy: therapy: ~ patients Carbon ion therapy: ~ patients t Rome SB - 5/5 32

33 Tumours of the central nervous system Control at 5 years RT Protons Chordomas 17-50% 73-83% Chondrosarcomas 50-60% 90-98% 98% Rome SB - 5/5 33

34 The map of hadrontherapy Rome SB - 5/5 34

35 What a patient sees Rome SB - 5/5 35

36 A ganrty for proton therapy Rome SB - 5/5 36

37 A research topic: proton radiography CT gives information on the density of electrons (Hounsfield numbers) CT is commonly used in diagnostics CT is commonly used in conventional radiation therapy to calculate the treatment planning X and MeV gamma rays interact with the electrons CT is used also in proton and ion therapy to calculate the treatment planning but Protons and ions interact with matter through de/dxdx -> density ρ, Z Compton effect is proportional to Z but not the photoelectric effect! Corrections are applied Rome SB - 5/5 37

38 Proton radiography and proton CT Radiography with X-rays Counts the number of photons (attenuation coefficient) Proton radiography Protons with enough energy to penetrate the body Residual range mesurement Rome SB - 5/5 38

39 Proton radiography Scintillating fibers Advantages No need for corrections like for X-ray CT Less dose to the patient (every proton brings information!) Disadvantages E. Pedroni et al., PSI Need of large accelerators usually used also for therapy (timing problem) For now it is a research issue (PSI) Rome SB - 5/5 39

40 Carbon ion therapy in Europe GSI pilot project (G. Kraft) 200 patients t treated t with carbon ions PET on-beam Rome SB - 5/5 40

41 PET on-beam Simulated from TPS Measurement of the real dose given to the patient Measured Rome SB - 5/5 41

42 HIT University of Heidelberg Carbon ion gantry MAN technology December 2006 Hospital based centre Architects Nickl & Partner, Munich and Heidelberg University Building Authority Project started in 2001 First patient treatment foreseen in 2007 Rome SB - 5/5 42

43 The TERA Foundation Not-for-profit foundation created in 1992 by Ugo Amaldi and recognized by the Italian Ministry of Health in 1994 Research in the field of particle accelerators and detectors for hadron-therapy First goal: the Italian National Centre (CNAO) now under construction in Pavia Ugo Amaldi Rome SB - 5/5 43

44 CNAO on the Pavia site Main source of funds: Italian Health Ministry Ground breaking: March m PIMMS/TERA Hospital based centre Design Protons and carbon ions Rome SB - 5/5 44

45 CNAO synchrotron hall in March 2007 Courtesy Sandro Rossi, Fondazione CNAO Rome SB - 5/5 45

46 Neutrons in cancer therapy Rome SB - 5/5 46

47 Hadrontherapy with fast neutrons Berkeley, 1938 Neutrons are neutral no Bragg peak MeV neutrons are produced with cyclotrons (p + Be reaction) MeV neutrons produce nuclear interactions high LET radiation Used for radio resistant tumours (ex. salivary glands, tongue, brain) About 9 centers in the world [ex. Orleans (France), Fermilab (USA)] Rome SB - 5/5 47

48 Boron Neutron Capture Therapy (BNCT) Concept proposed in 1936 by G.L. Locher (only 4 years after the discovery of the neutron!) Bring into cancer cells a nuclide that captures neutrons and disintegrates into high LET fragments 10 B is used Available (20% of natural B) Fragments of high LET and path lengths approximately one cell diameter (about 12 microns) Well known chemistry Rome SB - 5/5 48

49 BNCT facilities Nuclear reactors or accelarators are used as sources of epithermal neutrons Many centers in the world, mostly for clinical trials Limitation Difficult to achieve selective localization in the tumour! Rome SB - 5/5 49

50 End of part V Rome SB - 5/5 50

PROGRESS IN HADRONTHERAPY

PROGRESS IN HADRONTHERAPY PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy

More information

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY

SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SAVERIO BRACCINI * Albert Einstein Centre for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse

More information

Heavy Ion Tumor Therapy

Heavy Ion Tumor Therapy Heavy Ion Tumor Therapy Applications Bence Mitlasoczki 25.06.2018 Heidelberg 1. Source (H 2 /CO 2 ) 2. Linac 3. Synchrotron 4. Guide 5. Treatment rooms 6. X-ray system 7. Gantry 8. Treatment room with

More information

Introduction to Ion Beam Cancer Therapy

Introduction to Ion Beam Cancer Therapy Introduction to Ion Beam Cancer Therapy Andrew M. Sessler (with some slides from David Robin) Lawrence Berkeley National Laboratory Berkeley, CA 94720 Cyclotron 10, Lanzhou September 10, 2010 Contents

More information

A brief presentation of The TERA Foundation

A brief presentation of The TERA Foundation A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac

More information

ACCELERATORS FOR HADRONTHERAPY

ACCELERATORS FOR HADRONTHERAPY ACCELERATORS FOR HADRONTHERAPY Alberto Degiovanni CERN-BE IVICFA s Fridays: Medical Physics Valencia, 31.10.2014 Introduction: the icon of hadrontherapy Position of the Bragg peak depends on beam energy

More information

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE I. Petrovi a, A. Risti -Fira a, L. Kori anac a, J. Požega a, F. Di Rosa b, P. Cirrone b and G. Cuttone

More information

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca

More information

HEAVY PARTICLE THERAPY

HEAVY PARTICLE THERAPY HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER

More information

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy -

Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Takeshi Murakami Research Center of Charged Particle Therapy National Institute of Radiological Sciences 2012.11.21 1. Introduction to

More information

Progress of Heavy Ion Therapy

Progress of Heavy Ion Therapy Progress of Heavy Ion Therapy Fuminori Soga Division of Accelerator Physics and Engineering, National Institute of Radiological Sciences, 4-9-1 Anagawa. Inage-ku, Chiba 263-8555, Japan 1. Introduction

More information

Proton and heavy ion radiotherapy: Effect of LET

Proton and heavy ion radiotherapy: Effect of LET Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer

More information

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center Thomas Haberer, Scientific Technical Director, Heidelberg Ion Therapy Center Situation / Indications 2/3 patients suffer

More information

Neutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction

Neutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction Neutrons Neutrons act like photons in the sense that they are attenuated as I = I 0 e μx where Unlike photons, neutrons interact via the strong interaction μ = The cross sections are much smaller than

More information

Review of Hadron machines for cancer therapy

Review of Hadron machines for cancer therapy Review of Hadron machines for cancer therapy M. Kanazawa NIRS cancer therapy with hadron (p, C) Clinical studies at New ideas of accelerators Compact facilities (p, C) Depth dose distribution Carbon, proton

More information

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.

More information

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section

CERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section CERN: from particle physics to medical applications Manuela Cirilli CERN Knowledge Transfer Life Sciences Section The mission of CERN Research Innovation Push forward the frontiers of knowledge Develop

More information

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER Bro. Dr. Collie Miller IARC/WHO Based on trends in the incidence of cancer, the International Agency for Research on Cancer (IARC) and WHO

More information

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY

OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY Abstract The CNAO (National Centre for Oncological Hadrontherapy) has been realized in Pavia. It is a clinical facility created and financed by the Italian

More information

New Treatment Research Facility Project at HIMAC

New Treatment Research Facility Project at HIMAC New Treatment Research Facility Project at Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences IPAC10, Kyoto, JAPAN, 25th May, 2010 Contents 1. Introduction

More information

HADRONTHERAPY: a new frontier for cancer treatment

HADRONTHERAPY: a new frontier for cancer treatment Razionale HADRONTHERAPY: a new frontier for cancer treatment September, 19 20 2014 Hadrontherapy is a specific type of localized radiation therapy, which uses fast hadrons (charged particles made of quarks)

More information

Ion Beam Therapy should we prioritise research on helium beams?

Ion Beam Therapy should we prioritise research on helium beams? Ion Beam Therapy should we prioritise research on helium beams? Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION Beam Therapy: Clinical, Scientific

More information

Review of Heavy Ion Accelerators for Hadrontherapy

Review of Heavy Ion Accelerators for Hadrontherapy Review of Heavy Ion Accelerators for Hadrontherapy Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences 11 th Int l Conf. on Heavy Ion Accelerator Technology,

More information

A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe

A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe SEEIIST South East Europe International Institute for Sustainable Technologies A Facility for Tumour Hadron Therapy and Biomedical Research in South-Eastern Europe U. Amaldi a, J. Balosso b, M. Dosanjh

More information

Status of H 1 and C 12

Status of H 1 and C 12 Status of H 1 and C 12 Herman Suit No Conflict of Interest 1 Goal of a New Treatment Modality Tumor Control Probability or No in Complication Rate 2 Truism No Advantage to: any Patient for any Radiation

More information

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam University of Chicago CDH Proton Center LET study C. Reft 1, H. Ramirez 2 and M. Pankuch

More information

Today, I will present the second of the two lectures on neutron interactions.

Today, I will present the second of the two lectures on neutron interactions. Today, I will present the second of the two lectures on neutron interactions. 1 The main goal of this lecture is to tell you a little about clinical neutron therapy, first with fast neutron beams, and

More information

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Overview Introduction Overview Introduction Brachytherapy Radioisotopes in contact with the tumor Overview

More information

Neutron Radiotherapy: Past, Present, and Future Directions

Neutron Radiotherapy: Past, Present, and Future Directions Neutron Radiotherapy: Past, Present, and Future Directions Theodore L. Phillips Lecture -- 2014 George E. Laramore Ph.D., M.D. NONE Conflicts of Interest Peter Wootton Professor of Radiation Oncology University

More information

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics Neutron Interactions Part 2 George Starkschall, Ph.D. Department of Radiation Physics Neutron shielding Fast neutrons Slow down rapidly by scatter in hydrogenous materials, e.g., polyethylene, paraffin,

More information

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:

More information

Hampton University Proton Therapy Institute

Hampton University Proton Therapy Institute Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI

More information

Chapter Introduction

Chapter Introduction Chapter 1 Introduction Malignancy is a life-threatening condition in which tumor cells are of a highly invasive character and penetrate normal organs and exhibit an obstinate resistance against cancer

More information

Hypofractionation in particle therapy. Marco Durante

Hypofractionation in particle therapy. Marco Durante Hypofractionation in particle therapy Marco Durante 29.04.2014 Radiosurgery (SBRT): the new frontier in stereotactic imageguided radiotherapy Stage I (T1N0M0) NSCLC Oligometastases Hepatocellular carcinoma

More information

SUMITOMO Particle Therapy Technologies

SUMITOMO Particle Therapy Technologies 55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future

More information

An Introduction to Cancer Therapy With Hadron Radiation

An Introduction to Cancer Therapy With Hadron Radiation An Introduction to Cancer Therapy With Hadron Radiation Andrew M. Sessler Lawrence Berkeley National Laboratory Berkeley, CA 94720 April, 2008 Contents 1. History 2. X-Ray Machines 3. Why Hadrons? Which

More information

Tumor Therapy with Heavy Ions at GSI Darmstadt

Tumor Therapy with Heavy Ions at GSI Darmstadt Tumor Therapy with Heavy Ions at GSI Darmstadt D. Schardt 1) for the Heavy Ion Therapy Collaboration 2) 1) Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany 2) GSI Darmstadt / Radiologische

More information

Sarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington

Sarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Sarcoma and Radiation Therapy Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Objective: Helping you make informed decisions Introduction Process Radiation

More information

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May IONTRIS Synchrotron based PT Solutions from Siemens AG Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May 1 2009 Matthias Herforth VP Business Development and Communications Siemens AG

More information

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) Course Description: This course is an introduction to physics in medicine and is intended to introduce

More information

Nuclear Data for Radiation Therapy

Nuclear Data for Radiation Therapy Symposium on Nuclear Data 2004 Nov. 12, 2004 @ JAERI, Tokai Nuclear Data for Radiation Therapy ~from macroscopic to microscopic~ Naruhiro Matsufuji, Yuki Kase and Tatsuaki Kanai National Institute of Radiological

More information

Biological Optimization of Hadrontherapy. Uwe Oelfke

Biological Optimization of Hadrontherapy. Uwe Oelfke 4/2/2012 page 1 Biological Optimization of Hadrontherapy Uwe Oelfke DKFZ Heidelberg (E040) Im Neuenheimer Feld 280 69120 Heidelberg, Germany u.oelfke@dkfz.de 4/2/2012 page 2 Contents Introduction and General

More information

By Elizabeth Clements. Applications in cancer treatment

By Elizabeth Clements. Applications in cancer treatment Illustrations: Sandbox Studio, Chicago A new kind of detector technology that could lead to discoveries in particle physics may also lead to better 3D images of the human body and help cancer patients.

More information

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 The Heidelberg Ion Therapy Center Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 Goal The key element to improve the clinical outcome is local l control! entrance channel:

More information

Status of Proton Therapy: results and future trends

Status of Proton Therapy: results and future trends Status of Proton Therapy: results and future trends E. Pedroni Paul Scherrer Institute Division of Radiation Medicine CH-5232 Villigen PSI Abstract The number of centres investigating proton therapy in

More information

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy Radiation Dosimetry for Proton Therapy Narayan Sahoo Department of Radiation Physics University of Texas MD Anderson Cancer Center Proton Therapy Center Houston, USA Topics covered Detectors used for to

More information

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR Therapeutic Medical Physics Stephen J. Amadon Jr., Ph.D., DABR Outline 1. Why physicists are needed in medicine 2. Branches of medical physics 3. Physics in Radiation Oncology 4. Treatment types and Treatment

More information

Radiation physics and radiation protection. University of Szeged Department of Nuclear Medicine

Radiation physics and radiation protection. University of Szeged Department of Nuclear Medicine Radiation physics and radiation protection University of Szeged Department of Nuclear Medicine Radiation doses to the population 1 Radiation doses to the population 2 Sources of radiation 1 Radiation we

More information

Activities at the Heidelberg Ion Therapy Center (HIT)

Activities at the Heidelberg Ion Therapy Center (HIT) Activities at the Heidelberg Ion Therapy Center (HIT) The people A. Mairani (now INFN), F. Sommerer (Uniklinikum Heidelberg), I. Rinaldi (DKFZ Heidelberg), K. Parodi (HIT and University of Heidelberg)

More information

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *

MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * Radiation Protection Dosimetry (2009), Vol. 137, No. 1 2, pp. 156 166 Advance Access publication 14 October 2009 doi:10.1093/rpd/ncp192 MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * 1

More information

Nuclear Physics in Proton Radiotherapy

Nuclear Physics in Proton Radiotherapy Nuclear Physics in Proton Radiotherapy Cynthia Keppel, PhD Thomas Jefferson National Accelerator Facility (Hampton University Proton Therapy institute) International Nuclear Physics Conference Adelaide,

More information

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy C. Talamonti a*, M. Bucciolini a, L. Marrazzo a, D. Menichelli a. a) Department

More information

IMPT with Carbon Ions

IMPT with Carbon Ions IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de

More information

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 林口 Proton Therapy in Ti Taiwan *Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 Chang Gung Memorial Hospital at Lin-Kou, Taiwan 林口長庚紀念醫院 OCPA2010 at Beijing, China Aug. 5, 2010 Outline 1. The principle of proton radiotherapy

More information

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center The Heidelberg Ion Therapy Center and PARTNER Thomas Haberer Heidelberg Ion Therapy Center Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low

More information

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center The Heidelberg Ion Beam Therapy Center A Hospital-based Facility Dedicated to Precision and Flexibility Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center Carbon Ion Therapy

More information

Option D: Medicinal Chemistry

Option D: Medicinal Chemistry Option D: Medicinal Chemistry Basics - unstable radioactive nuclei emit radiation in the form of smaller particles alpha, beta, positron, proton, neutron, & gamma are all used in nuclear medicine unstable

More information

Modelling the induction of cell death and chromosome damage by therapeutic protons

Modelling the induction of cell death and chromosome damage by therapeutic protons Modelling the induction of cell death and chromosome damage by therapeutic protons M.P. Carante 1,2 and F. Ballarini 1,2, * 1 University of Pavia, Physics Department, Pavia, Italy 2 INFN, Sezione di Pavia,

More information

Status of Hadrontherapy facilities worldwide

Status of Hadrontherapy facilities worldwide Status of Hadrontherapy facilities worldwide Vienna 15.03.2011 The Gantry 1 of PSI Eros Pedroni Center for Proton Radiation Therapy Paul Scherrer Institute SWITZERLAND Author s competence: Gantry with

More information

Recent advances in dosimetry in reference conditions for proton and light-ion beams

Recent advances in dosimetry in reference conditions for proton and light-ion beams Recent advances in dosimetry in reference conditions for proton and light-ion beams S. Vatnitskiy a), P. Andreo b) and D.T.L. Jones c) a) MedAustron, Wiener Neustadt, Austria b) Medical Radiation Physics,

More information

Present status and future of Proton beam therapy

Present status and future of Proton beam therapy Present status and future of Proton beam therapy Description At present, the types of proven treatment for cancer are surgery, radiotherapy, and chemotherapy. Depending on the characteristics of cancer

More information

Cancer situation as presented by (EC 1991)

Cancer situation as presented by (EC 1991) 3.1 Proton and Heavy Ion Beam Therapy G. Kraft, GSI, Biophysik, Darmstadt and J. Debus, DKFZ, Heidelberg Motivation Cancer is the second most frequent cause for disease in the developed countries. Every

More information

Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions.

Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions. Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions. A treatment planning study performed on water phantoms

More information

Radiobiology for particle therapy

Radiobiology for particle therapy Radiobiology for particle therapy Marco Durante CNAO-NIRS meeting, Pavia 21.03.2010 INFN Workshop, Napoli, 4.4.2014 2 The radiobiological adavantages of particle therapy Jakob et al., PNAS 2009 PIDE database

More information

A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September

A review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September A review of cyclotrons for Hadron Therapy Y. Jongen Cyclotrons 2010 Lanzhou, September 10 2010 The early days The possible use of the Bragg peak of high energy ions in the radiotherapy of cancer was suggested

More information

Basic Press Information

Basic Press Information Basic Press Information Contact MedAustron EBG MedAustron GmbH Marie Curie-Strasse 5 A-2700 Wiener Neustadt Austria T +43 2622 26 100-0 e-mail: office@medaustron.at Internet: www.medaustron.at Press contact:

More information

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Proton Therapy Dosimetry & Clinical Implementation Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Outline» Proton Therapy Basics» Why Proton Therapy? (Dosimetric Superiority)»

More information

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY

ACCELERATOR DESIGN ISSUES IN CANCER THERAPY ACCELERATOR DESIGN ISSUES IN CANCER THERAPY December 25 P.J. Bryant CERN John ADAMS Memorial Lecture 25- P.J. Bryant - Slide 1 Contents Introduction Hadrons & voxel scanning Experimental setup A closer

More information

Proton and helium beams: the present and the future of light ion beam therapy

Proton and helium beams: the present and the future of light ion beam therapy Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation

More information

Hadrons on Malignant Cells: Recent Activities within Collaboration between LNS INFN and Vinca Institute of Nuclear Sciences

Hadrons on Malignant Cells: Recent Activities within Collaboration between LNS INFN and Vinca Institute of Nuclear Sciences ENSAR2 Midterm Meeting of Networking Activity 5: MediNet March 12 th 14 th, 218 Vinča Institute of Nuclear sciences, University of Belgrade Hadrons on Malignant Cells: Recent Activities within Collaboration

More information

THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY. S.V. Akulinichev, A. V. Andreev, V.M. Skorkin

THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY. S.V. Akulinichev, A. V. Andreev, V.M. Skorkin THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY S.V. Akulinichev, A. V. Andreev, V.M. Skorkin Institute for Nuclear Research of the RAS, Russia THE PROJECT OF NEUTRON SOURCES FOR THE NEUTRON

More information

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy C. Talamonti M. Bruzzi,M. Bucciolini, L. Marrazzo, D. Menichelli University of

More information

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology PRINCIPLES and PRACTICE of RADIATION ONCOLOGY Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology OUTLINE Physical basis Biological basis History of radiation therapy Treatment planning Technology

More information

Your co-operation partner for research. EUROPEAN UNION European Regional Development Fund

Your co-operation partner for research. EUROPEAN UNION European Regional Development Fund Med Austron Research Your co-operation partner for research EUROPEAN UNION European Regional Development Fund MedAustron MedAustron offers protons and carbon ions for therapy and research. With MedAustron,

More information

Particle Therapy- Why?

Particle Therapy- Why? Particle Therapy- Why? Kill tumour without affecting healthy cells X-Ray Therapy Head, neck, Spinal cord Eyes, orbits Pelvis Prostate Lung PEDIATRIC Proton Therapy Photon IMRT Photon Proton (Courtesy of

More information

ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING.

ABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING. P ROTON THERAPY C O- OPERATIVE GROUP Chair Michael Goitein Ph. D. Department of Radiation Oncology Massachusetts General Hospital Boston MA 02114 (617) 724-9529 (617) 724-9532 Fax Secret ary Janet Sisterson

More information

Applications of Particle Accelerators

Applications of Particle Accelerators Applications of Particle Accelerators Prof. Rob Edgecock STFC Rutherford Appleton Laboratory EMMA Accelerator at Daresbury Laboratory Applications >30000 accelerators in use world-wide: 44% for radiotherapy

More information

AMERICAN BRAIN TUMOR ASSOCIATION. Proton Therapy

AMERICAN BRAIN TUMOR ASSOCIATION. Proton Therapy AMERICAN BRAIN TUMOR ASSOCIATION Proton Therapy ACKNOWLEDGEMENTS ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit

More information

Particle Radiation Therapy. Sophi Farid Phys 3305 Southern Methodist University Spring 2016

Particle Radiation Therapy. Sophi Farid Phys 3305 Southern Methodist University Spring 2016 1 Particle Radiation Therapy Sophi Farid Phys 3305 Southern Methodist University Spring 2016 2 Outline I. What is Cancer II. Typical Cancer treatment III. How is particle radiation different IV. Particle-Tissue

More information

NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland

NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY Pawel Olko Institute of Nuclear Physics Krakow Poland The NuPECC report: Nuclear Physics in Medicine http://www.nupecc.org/pub/npmed2014.pdf Outline 1. Why

More information

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS Prof. Marco Durante Risk from neutrons Risk from exposure to fission spectrum neutrons has been extensively studied in the 60 s at nuclear reactors using animal

More information

Multi-Ion Analysis of RBE using the Microdosimetric Kinetic Model

Multi-Ion Analysis of RBE using the Microdosimetric Kinetic Model Multi-Ion Analysis of RBE using the Microdosimetric Kinetic Model Council of Ionizing Radiation Measurements and Standards (CIRMS) March 28 th, 2017 Michael P. Butkus 1,2 Todd S. Palmer 2 1 Yale School

More information

Lecture 13 Radiation Onclolgy

Lecture 13 Radiation Onclolgy Lecture 13 Radiation Onclolgy Radiation Oncology: Tumors attacked with ionizing radiation Photons (gamma rays) High Energy Electrons Protons Other particles Brachytherapy: implants of beta emitters Ionizing

More information

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS

TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS TERA PROGRAMME: MEDICAL APPLICATIONS OF PROTONS AND IONS Ugo Amaldi CERN, 1211-Geneva 23, Switzerland and TERA Foundation, Via Puccini 11, 28100-Novara, Italy Abstract The most recent applications of hadron

More information

Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR:

Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR: НТС ОЭЗ, 07 октября 2011 Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR: Development of 3D conformal Proton therapy Design of various devices for proton

More information

Advances in external beam radiotherapy

Advances in external beam radiotherapy International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada

More information

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN

HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN S. Yamada, T. Honma, M. Kanazawa, A. Kitagawa, S. Kouda, M. Kumada, T. Murakami, M. Muramatsu, T. Nishio, K. Noda, Y. Sato, M. Suda and E. Takada, Research

More information

V. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT

V. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT CYRIC Annual Report 2002 V. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT Yonai S., ItogaT., Nakamura T., Baba M., Yashima, H. Yokobori H. *, and Tahara Y. ** Cyclotron

More information

Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry

Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry M. Caresana a, A. Sashala Naik a,c, S. Rollet b, M. Ferrarini a,d a Polytechnic

More information

Medical Use of Radioisotopes

Medical Use of Radioisotopes Medical Use of Radioisotopes Therapy Radioisotopes prove to be useful in the application of brachytherapy, the procedure for using temporary irradiation close to the area of disease (i.e. cancer) 10% Medical

More information

Progress in Reactor and Accelerator Based BNCT at Kyoto University Research Reactor Institute

Progress in Reactor and Accelerator Based BNCT at Kyoto University Research Reactor Institute Progress in Reactor and Accelerator Based BNCT at Kyoto University Research Reactor Institute Yoshinori Sakurai 1 Kyoto University Research Reactor Institute Asashiro-nishi 2-1010, Kumatori-cho, Sennan-gun,

More information

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments Alana Hudson *1 1 Tom Baker Cancer Centre, Department of Medical Physics, 1331

More information

Intensity Modulated RadioTherapy

Intensity Modulated RadioTherapy Intensity Modulated RadioTherapy A clinical application of a small accelerator University Medical Center Groningen A.A. van t Veld PhD I. Hoveijn PhD part 1 part2 CERN/KVI accelerator school, Zeegse, June

More information

Radiation protection in proton therapy

Radiation protection in proton therapy Radiation protection in proton therapy Pieternel van der Tol Medical Physicist - HollandPTC pvandertol@hollandptc.nl Marjan Dwarswaard René Bolt Marc-Jan van Goethem Lars Murrer Outline Introduction Interactions

More information

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034

Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Saudi-Japan Business Opportunities Forum February 1 2, 2012 1 2 Types of Treatment Conventional Radiation Therapy Uses photons (energetic

More information

Radiation Exposure and Image Quality in X-Ray Diagnostic Radiology

Radiation Exposure and Image Quality in X-Ray Diagnostic Radiology Horst Aichinger Joachim Dierker Sigrid Joite-Barfuß Manfred Säbel Radiation Exposure and Image Quality in X-Ray Diagnostic Radiology Physical Principles and Clinical Applications Second Edition Springer

More information

The impact of different radiation qualities on cancer cells

The impact of different radiation qualities on cancer cells The impact of different radiation qualities on cancer cells Marjan Moreels, PhD Radiobiology Unit,, Belgium XXth Colloque GANIL Session 10, Amboise, France Oct 19, 2017 1 The Belgian Nuclear Research Center

More information

A fast Monte Carlo toolkit on GPU for treatment plan dose recalculation in proton therapy

A fast Monte Carlo toolkit on GPU for treatment plan dose recalculation in proton therapy A fast Monte Carlo toolkit on GPU for treatment plan dose recalculation in proton therapy Martina Senzacqua PhD student in Accelerator Physics at University of Rome La Sapienza Department of Basic and

More information

Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience

Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Stephanie E. Combs, MD Department of Radiation Oncology University of Heidelberg, Germany Carbon ion RT at GSI Active beam delivery

More information